Creating a healthy workplace environment should be at the top of any employers list. This resource includes strategies that support employees with ADPKD. Read More
This study was conducted to develop screening and diagnostic criteria with emphasis on divergent ADPKD mutations. Read inside to learn the results and more. Read More
It was found that there is a strong association between end-stage renal disease and total kidney volume. Read inside for more details and clinical implications. Read More
This article reviews study findings to determine the reliability of ultrasound and kidney measurement in predicting ADPKD progression. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.